The following is a summary of “Efficacy and Safety of Obeticholic Acid for Treating Hepatic Steatosis in Patients with Familial Partial Lipodystrophy,” published in the March 2025 issue of Journal of Clinical Endocrinology & Metabolism by Garg et al. Individuals with familial partial lipodystrophy (FPLD) faced a higher risk of hepatic steatosis and its complications, […]
The post Obeticholic Acid Reduces Liver Fat in Individuals With FPLD2 first appeared on Physician’s Weekly.
